Ksolves India Limited (BOM:543599)

Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	7,491	10,354	13,266	5,243	4,204	1,037
Market Cap Growth	-39.94%	-21.95%	153.01%	24.74%	305.20%	-
Enterprise Value	7,476	10,198	13,164	5,180	4,139	1,039
Last Close Price	315.90	434.51	539.82	207.81	-	-
PE Ratio	23.56	30.17	38.84	21.21	26.45	11.61
PS Ratio	5.22	7.53	12.21	6.70	8.93	3.68
PB Ratio	36.09	49.89	55.67	23.43	25.21	7.76
P/TBV Ratio	36.20	50.03	55.81	23.49	25.30	7.80
P/FCF Ratio	-	38.52	42.72	26.05	43.55	21.64
P/OCF Ratio	-	30.35	39.91	25.32	41.24	20.69
EV/Sales Ratio	5.21	7.42	12.12	6.62	8.79	3.68
EV/EBITDA Ratio	16.37	21.31	28.14	15.67	20.35	8.30
EV/EBIT Ratio	17.34	22.34	28.67	15.93	20.85	8.56
EV/FCF Ratio	-	37.94	42.39	25.74	42.89	21.67
Debt / Equity Ratio	0.43	0.43	-	-	-	0.01
Debt / EBITDA Ratio	0.20	0.19	-	-	-	0.01
Debt / FCF Ratio	-	0.34	-	-	-	0.02
Asset Turnover	-	2.87	2.95	2.71	2.30	2.92
Quick Ratio	-	1.15	1.71	2.30	2.58	3.32
Current Ratio	-	1.69	2.64	3.10	3.50	4.33
Return on Equity (ROE)	-	153.95%	147.80%	126.58%	105.82%	125.54%
Return on Assets (ROA)	-	59.47%	77.94%	70.36%	60.66%	78.62%
Return on Capital (ROIC)	100.55%	106.47%	124.19%	104.07%	82.38%	104.61%
Return on Capital Employed (ROCE)	-	158.40%	177.40%	137.00%	114.40%	89.00%
Earnings Yield	4.24%	3.31%	2.57%	4.71%	3.78%	8.62%
FCF Yield	-	2.60%	2.34%	3.84%	2.30%	4.62%
Dividend Yield	3.79%	3.57%	1.81%	5.65%	-	-
Payout Ratio	-	107.09%	95.46%	76.08%	77.35%	16.58%
Buyback Yield / Dilution	-0.07%	-0.03%	-	-	-	-586.89%
Total Shareholder Return	3.72%	3.54%	1.81%	5.65%	-	-586.89%

Updated Jan 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.